2024, Cilt 54, Sayı 2, Sayfa(lar) 152-156 |
[ Türkçe Özet ]
[ PDF ]
[ Benzer Makaleler ]
|
Antibiotic Resistance in Globicatella sanguinis Isolated From A Ventriculoperitoneal Shunt Infection: A Case Report |
Zeynep Nazlıkaya Erdem1, Ozan Çıvgın2, Gökçe Sucuer Akarca1, Mesut Mete2, Hörü Gazi1 |
1Manisa Celal Bayar Üniversitesi, Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Manisa, Türkiye 2Manisa Celal Bayar Üniversitesi, Tıp Fakültesi, Beyin ve Sinir Cerrahisi Anabilim Dalı, Manisa, Türkiye |
Keywords: Globicatella sanguinis, MALDI-TOF MS, antibiotic susceptibility |
Globicatella sanguinis is a catalase-negative, rare gram-positive coccus. Due to its morphological similarity
to viridans streptococci, identification of the pathogen at the species level using conventional phenotypic
identification methods is difficult. The recent introduction of mass spectrometry have demonstrated that G.
sanguinis caused more infections than previously thought.
The aim of this study is to present a case of ventriculoperitoneal shunt infection caused by G. sanguinis. A
77-year-old female was admitted to our hospital with complaints of urinary incontinence, amnesia, and difficulty
in walking. The patient had underwent ventriculoperitoneal shunt surgery. The patient was discharged in good
condition, but was admitted again after 18 days due to high fever. Upon physical examination, an abdominal
fistula and discharge were observed, and the patient underwent surgery again. After taking of cerebrospinal
fluid from the abdominal and ventricular ends of the ventriculoperitoneal shunt, the shunt system was removed,
and an external ventricular drainage system was inserted. The cerebrospinal fluid samples, obtained from the
ventriculoperitoneal shunt and the external ventricular drainage system were sent to Bacteriology Laboratory.
The bacteria with gram-positive coccus morphology were identified as G. sanguinis by the Bruker IVD MALDI
Biotyper 2.3 (Bruker Daltonik GmbH) device. By the E test (BioMeriuex, France), the agent was found to be
resistant to ceftriaxone and susceptible to high-dose penicillin. To provide the most appropriate treatment
to the patient, accurate identification of the causative agent and informing the clinicians on the antibiotic
resistance profile are needed.
|
[ Türkçe Özet ]
[ PDF ]
[ Benzer Makaleler ]
|